Results 201 to 210 of about 262,681 (286)

Retraction: miR-34a modulates Angiotensin II-induced myocardial hypertrophy by direct inhibition of ATG9A expression and Autophagic activity. [PDF]

PLoS One
PLOS One Editors.
europepmc   +1 more source

The ADESTE trial: A phase 2 study of enibarcimab, a monoclonal antibody targeting adrenomedullin, in acute heart failure

ESC Heart Failure, EarlyView.
Abstract Aims This study aimed to conduct a phase 2 proof‐of‐concept and safety study to evaluate the effect of ENIBARCIMAB (EN), a non‐neutralizing humanized monoclonal antibody targeting the N‐terminus of adrenomedullin (ADM), administered immediately after stabilization with standard of care (SoC) treatment, in patients hospitalized for acute heart ...
Anggoro Budi Hartopo, Arinal Chairul Achyar, Hendry Purnasidha Bagaswoto, Firandi Saputra, Hasanah Mumpuni, Dyah Adhi Kusumastuti, Teguh Triyono, Usi Sukorini, Metalia Puspitasari, Budi Yuli Setianto, Mohammad Saifur Rohman, Muhammad Anshory, Yoga Waranugraha, Putri Annisa Kamila, Agustin Iskandar, Hani Susianti, Andreas Bergman, Claudia Knothe, Paola Antonini, Salvatore Di Somma   +19 more
wiley   +1 more source

Frataxin Loss Promotes Angiotensin II-Induced Endothelial-to-Mesenchymal Transition. [PDF]

J Am Heart Assoc
Guo Y, Cheng X, Huang C, Gao J, Shen W.
europepmc   +1 more source

Severity of tricuspid regurgitation predicts risk of recurrence of atrial fibrillation after pulmonary vein isolation

ESC Heart Failure, EarlyView.
Abstract Aims Tricuspid regurgitation (TR) results in right atrial remodelling, thus promoting the formation of a substrate for atrial fibrillation (AF). In turn, AF may cause TR by annulus dilatation. We investigated whether the presence of TR affects the efficacy of pulmonary vein isolation (PVI) for AF. Methods and results In patients undergoing PVI,
Jan Wintrich, Dimitrios Bismpos, Anika Teusch, Valerie Pavlicek, Patrick Fischer, Felix Mahfoud, Michael Böhm, Christian Ukena   +7 more
wiley   +1 more source

Angiotensin II administration in severe thrombocytopenia and chronic venous thrombosis: A case report.

World J Crit Care Med
Vujaklija Brajkovic A, Markota A, Bielen L, Vujević A, Rora M, Radonic R.   +5 more
europepmc   +1 more source

Labial adhesions due to vulvovaginal lichen planus suspected to be caused by angiotensin II receptor blocker. [PDF]

IJU Case Rep
Sawada Y, Kitagawa Y, Tanaka A, Harada S, Nomura MJ.   +4 more
europepmc   +1 more source

Predicting right ventricular failure after left ventricular assist device implant: A novel approach

ESC Heart Failure, EarlyView.
Abstract Aims Right ventricular (RV) failure (RVF) after left ventricular assist device (LVAD) implant is an important cause of morbidity and mortality. Modern, data‐driven approaches for defining and predicting RVF have been under‐utilized. Methods Two hundred thirty‐two patients were identified with a mean age of 55 years; 40 (17%) were women, 132 ...
Carissa E. Livingston, Dale Kim, Lacey Serletti, Andrea Jin, Sriram Rao, Michael V. Genuardi, Eliot G. Peyster   +6 more
wiley   +1 more source

Alantolactone mitigates the elevation of blood pressure in mice induced by angiotensin II by inhibiting calcium channel activation. [PDF]

BMC Cardiovasc Disord
Yuan R, Gao M, Xu H, Liang Q, Qian L, Wang Y, Zhang H, Qiang E, Yun W.   +8 more
europepmc   +1 more source

Poor communication impairs optimal care of patients with heart failure and erectile dysfunction

ESC Heart Failure, EarlyView.
Abstract Aims Heart failure (HF) and erectile dysfunction (ED) share numerous risk factors and pathogenetic mechanisms, resulting in a high prevalence of ED among male patients with HF. This questionnaire‐based study aimed to better understand the patient's journey from a patient perspective and that of healthcare professionals (HCPs) regarding ...
Lea Leist, Lenka Hausmann, Carla Pohlink
wiley   +1 more source

Identification of angiotensin II-responsive circadian clock gene expression in adrenal zona glomerulosa cells and human adrenocortical H295R cells. [PDF]

Front Endocrinol (Lausanne)
Otani T, Miyake T, Ota T, Yarimizu D, Nakagawa Y, Murai I, Okamura H, Hasegawa E, Doi M.   +8 more
europepmc   +1 more source